From vision defects to rainbows and sky colour, here’s a quick-scoring, concept-based summary aligned with the CBSE dual exam system.

Flavio Mantelli, MD, PhD, OKYO Pharma Chief Medical Officer Dr. Mantelli will lead the clinical and regulatory strategy to ...

SHELTON, CONNECTICUT / ACCESS Newswire / February 12, 2026 / NanoViricides, Inc., a publicly traded company (NYSE ...

After the advent of gene-editing technology, if it can lead to disease treatment, the question naturally moves to the next ...

Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for subcutaneous amivantamab and hyaluronidase-lpuj as ...

Humans develop sharp vision during early fetal development thanks to an interplay between a vitamin A derivative and thyroid hormones in the retina, Johns Hopkins University scientists have found.

Glaukos Corporation (NYSE:GKOS) Q4 2025 Earnings Call Transcript February 17, 2026 Glaukos Corporation misses on earnings ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

Parasites and infections that cause blindness and other disabilities were nearly eliminated in some countries, but drug distribution to prevent and treat them was derailed in many places in 2025 after ...

New Dupixent® (dupilumab) data highlight its clinical and real-world impact across dermatological, respiratory and gastrointestinal diseases, including analyses of food allergy sensitization in ...

Thank you for standing by, and welcome to the Krystal Biotech 4Q 2025 Conference Call. [Operator Instructions] As a reminder, today's conference is being recorded. I would now like to hand the ...

We Don’t Know if the Models Are Conscious’ transcript I want to try and focus on scenarios where A.I. goes rogue. I should have had a picture of a Terminator robot to scare people as much as possible.